SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000009
Filing Date
2024-01-17
Accepted
2024-01-17 08:35:57
Documents
18
Period of Report
2024-01-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240117.htm   iXBRL 8-K 23626
2 EX-99.1 eliciotherapeutics_ascog.htm EX-99.1 13938
6 eliciotherapeutics_ascog001.jpg GRAPHIC 264478
7 eliciotherapeutics_ascog002.jpg GRAPHIC 233116
8 eliciotherapeutics_ascog003.jpg GRAPHIC 271009
9 eliciotherapeutics_ascog004.jpg GRAPHIC 291642
10 eliciotherapeutics_ascog005.jpg GRAPHIC 38642
  Complete submission text file 0001601485-24-000009.txt   1689309

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240117.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240117_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240117_pre.xml EX-101.PRE 13130
12 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240117_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 24536808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)